003020SZSE

Hefei Lifu Pharmaceutical Co., Ltd. 2025 Annual Shareholders' Meeting Resolution Announcement

Hefei Lifeon Pharmaceutical Co., Ltd.··3 pages

✨ AI Summary

Hefei Lifu Pharmaceutical Co., Ltd. held its 2025 Annual Shareholders' Meeting on May 18, 2026. The meeting approved all proposals, including the 2025 annual report, board of directors' report, profit distribution plan, and the appointment of the 2026 financial auditor. The resolutions passed with significant majority votes, confirming the meeting's procedural compliance.

Summary generated by AI · Always verify with source document

Full Translation

AI Translation· gemini_document

Securities Code: 003020 Securities Abbreviation: Lifu Pharmaceutical Announcement No.: 2026-018

Hefei Lifu Pharmaceutical Co., Ltd. 2025 Annual Shareholders' Meeting Resolution Announcement

The Company and the Board of Directors guarantee that the information disclosed is true, accurate, and complete, and contains no false records, misleading statements, or major omissions.

Special Notes:

  1. No proposals were rejected at this shareholders' meeting.
  2. This shareholders' meeting does not involve any changes to resolutions previously passed by shareholders' meetings.

I. Meeting Convening and Attendance

  1. Meeting Time (1) On-site meeting time: May 18, 2026 (Monday) at 14:30. (2) Online voting time: Voting time through the Shenzhen Stock Exchange trading system: May 18, 2026, 9:15-9:25, 9:30-11:30, 13:00-15:00; Voting time through the Shenzhen Stock Exchange internet voting system: May 18, 2026, 9:15-15:00.

  2. On-site meeting location: Conference Room 5, Research and Development Complex Building, No. 446 Wenqu Road, Hefei City, Anhui Province.

  3. Meeting method: A combination of on-site voting and online voting.

  4. Meeting convener: The Company's Board of Directors.

  5. Meeting chairperson: Mr. Ji Junqiu, Chairman of the Company.

  6. The convening, holding, and voting procedures of this meeting comply with the "Company Law of the People's Republic of China" and other relevant laws, regulations, normative documents, and the "Articles of Association".

  7. Meeting attendance (1) Overall attendance A total of 115 shareholders and shareholder representatives attended the meeting in person and online, representing 123,931,636 shares, accounting for 65.1647% of the Company's total voting shares. Of these: 17 shareholders and shareholder representatives attended the meeting in person (representing 18 shareholders), holding 112,419,892 shares, accounting for 59.1117% of the Company's total voting shares. Shareholders attending via online voting

97 shareholders, representing 11,511,744 shares, accounting for 6.0530% of the Company's total voting shares. (2) Attendance of small and medium shareholders A total of 108 small and medium shareholders and their representatives attended the meeting in person and online, representing 20,741,586 shares, accounting for 10.9062% of the Company's total voting shares. Of these: 11 small and medium shareholders and their representatives attended the meeting in person, representing 9,229,842 shares, accounting for 4.8532% of the Company's total voting shares. 97 small and medium shareholders and their representatives attended via online voting, representing 11,511,744 shares, accounting for 6.0530% of the Company's total voting shares.

  1. All directors of the Company and some senior management personnel attended the meeting. The witnessing lawyer attended the meeting to provide legal verification.

II. Proposal Review and Voting Results

The shareholders' meeting adopted a combination of on-site and online voting methods. The following proposals were reviewed and approved:

Sign in to read the full translation

Free accounts get 10 full releases per month. Pro subscribers get unlimited access.

Sign in to read moreSee Pro pricing